1.98
Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
2.17%
23.02
|
22.53 | 26.65 | 31.82 | 30.61 |
| Interest Income/Expense |
6.13%
0.383
|
0.408 | 0.405 | 0.406 | 0.427 |
| Depreciation and Amortization |
50.00%
0.10
|
0.20 | 0.20 | 0.20 | 0.20 |
| Operating Income/Loss |
2.17%
-23.02
|
-22.53 | -26.65 | -31.82 | -30.61 |
| Income/Loss From Continuing Operations Before Tax |
3.18%
-22.85
|
-22.14 | -25.95 | -30.75 | -29.16 |
| Income/Loss From Continuing Operations After Tax |
3.18%
-22.85
|
-22.14 | -25.95 | -30.75 | -29.16 |
|
|
3.18%
-22.85
|
-22.14 | -25.95 | -30.75 | -29.16 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.62%
0.2061
|
53.58 | 53.45 | 53.36 | 0.6304 |
| Diluted Average Shares |
99.62%
0.2061
|
53.58 | 53.45 | 53.36 | 0.6304 |
| Basic Earnings Per Share |
2.44%
-0.42
|
-0.41 | -0.49 | -0.58 | -0.53 |
| Diluted Earnings Per Share |
2.44%
-0.42
|
-0.41 | -0.49 | -0.58 | -0.53 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):